5Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176. 被引量:1
6Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616. 被引量:1
7Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687. 被引量:1
8Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301. 被引量:1
9Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002. 被引量:1
10Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166. 被引量:1
2De Gramont A, Krulik M, Cady J, et al. High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.Eur J Cancer Clin Oncol, 1988, 24:1499-1503. 被引量:1
3Ajani JA. Current status of therapy for advanced gastric carcinoma.Oncology, 1998, 12:99-102. 被引量:1
4Raymond E, Charley SG, Taamma A, et al. Oxaliplatin: a review of preclinical and clinical studies. Ann Oncol, 1998, 9:1053-1071. 被引量:1
5De Gramont A, Figer A, Seymonr M, et al. Leucovorin and fluorouracil with or without oxaliplatin as frist-line treatment in advanced colorectal cancer. J Clin Oncol, 2000,18:2938-2947. 被引量:1
6De Gramont A, Bosset JF, Milan C, et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly highdose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer : a French intergroup study. J Clin Oncol,1997, 15:808-815. 被引量:1